申请人:Nandy Sandip K.
公开号:US20100016347A1
公开(公告)日:2010-01-21
The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.
本发明涉及酪氨酸酶抑制剂,包含此类酪氨酸酶抑制剂的药物组合物,以及制备和使用这些药物的方法。具体而言,本发明包括至少一种2,4-二羟基苯类似物组成的物质组合物,这些组合物抑制酪氨酸酶的活性并抑制黑色素的过度产生。